StockData
NUSNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31

NU SKIN ENTERPRISES, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$4.97−0.17 (-3.31%)

Close on Oct 19, 2026

Market cap
$241.52M
P/E (TTM)
–
Dividend yield
–

Nu Skin Enterprises statistics

Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Wholesale-Drugs, Proprietaries & Druggists' Sundries companies for comparison

Valuation

MeasureNu Skin EnterprisesIndustry median
Market Cap$241.92M$71.31M
Enterprise Value$264.20M$153.86M
PS Ratio0.180.28
PB Ratio0.451.58
P/TBV Ratio0.481.77
P/FCF Ratio22.4414.21
P/OCF Ratio4.769.80

Enterprise value

MeasureNu Skin EnterprisesIndustry median
EV / Sales0.190.40
EV / EBITDA6.6710.71
EV / FCF24.5118.61

Income (trailing twelve months)

MeasureNu Skin EnterprisesIndustry median
Revenue$1.38B$716.39M
Gross Profit$951.49M$163.57M
Operating Income-$10.41M-$30.27K
Pretax Income-$26.39M$413.10K
Net Income-$216.39M-$63.82K
EBITDA$39.60M$2.60M
EPS (Diluted)-$4.47$0.02

Margins

MeasureNu Skin EnterprisesIndustry median
Gross Margin69.2%14.7%
Operating Margin-0.76%0.44%
Pretax Margin-1.92%0.25%
Profit Margin-15.7%-0.13%
EBITDA Margin2.88%1.23%
FCF Margin0.78%0.98%

Returns

MeasureNu Skin EnterprisesIndustry median
Return on Equity (ROE)-32.5%-0.53%
Return on Assets (ROA)-16.9%-0.67%
Return on Invested Capital (ROIC)-1.23%3.04%
Return on Capital Employed (ROCE)-1.20%4.42%

Growth

MeasureNu Skin EnterprisesIndustry median
Revenue Growth (YoY)-15.4%3.83%
Net Income Growth (YoY)-314.6%-4.31%
EPS Growth (YoY)-322.4%-3.40%
FCF Growth (YoY)-81.6%4.91%
Revenue Growth (3Y CAGR)-12.6%0.59%
Revenue Growth (5Y CAGR)-10.5%7.57%
EPS Growth (3Y CAGR)15.4%4.42%
EPS Growth (5Y CAGR)-2.61%7.47%

Balance sheet

MeasureNu Skin EnterprisesIndustry median
Cash & Short-Term Investments$191.39M$9.33M
Total Debt$213.66M$349.35M
Net Cash (Debt)-$22.28M-$1.85M
Net Cash Per Share-$0.46-$0.06
Equity (Book Value)$542.74M$16.46M
Book Value Per Share$11.15$0.34
Tangible Book Value$500.11M$8.19M
Working Capital$251.80M$12.53M

Financial position

MeasureNu Skin EnterprisesIndustry median
Current Ratio1.981.31
Quick Ratio0.940.55
Debt / Equity0.390.59
Debt / EBITDA5.403.43
Debt / FCF19.824.86
Net Debt / EBITDA0.562.77
Interest Coverage-0.660.82

Cash flow (trailing twelve months)

MeasureNu Skin EnterprisesIndustry median
Operating Cash Flow$50.81M$3.55M
Capital Expenditures-$40.03M-$34.65M
Free Cash Flow$10.78M$15.14M
FCF Per Share$0.22$0.38

Efficiency

MeasureNu Skin EnterprisesIndustry median
Asset Turnover1.071.65
Inventory Turnover2.289.79
Revenue Per Employee$108.23K$921.75K
Profits Per Employee-$17.03K-$1.01K
Employee Count12,707687

Dividends and yields

MeasureNu Skin EnterprisesIndustry median
Earnings Yield-89.4%-0.30%
FCF Yield4.46%4.46%
Buyback Yield8.28%0.28%
Shareholder Yield8.28%0.83%
FCF Payout Ratio108.1%35.0%

Shares

MeasureNu Skin EnterprisesIndustry median
Shares Outstanding48,676,60032,773,350
Shares Change (YoY)-0.11%0.00%
Float46,032,50022,533,950
Shares Held by Insiders5.43%8.34%
Shares Held by Institutions74.4%76.1%

Taxes

MeasureNu Skin EnterprisesIndustry median
Income Tax$190.00M$3.29M

Scores

MeasureNu Skin EnterprisesIndustry median
Altman Z-Score3.723.72
Piotroski F-Score74

Calculated by StockData from Nu Skin Enterprises's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.